Lista de obras - Margaret Sullivan Pepe - Dominio Público Uruguay

A Framework for Evaluating Markers Used to Select Patient Treatment ⬇️

artículo científico publicado el 27 de junio de 2013

A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis

artículo científico publicado en 2017

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection

artículo científico publicado en 2003

A framework for evaluating diagnostic discordance in pathology discovered during research studies

artículo científico publicado en 2014

A practical multifaceted approach to selecting differentially expressed genes

artículo científico publicado en 2007

Accommodating Covariates in ROC Analysis

artículo científico publicado en 2009

Adding Rigor to Biomarker Evaluations - EDRN Experience

artículo científico publicado en 2020

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

artículo científico publicado en 2009

Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting

artículo científico publicado en 2008

Adopting nested case–control quota sampling designs for the evaluation of risk markers ⬇️

artículo científico publicado el 27 de junio de 2013

An approach to evaluating and comparing biomarkers for patient treatment selection

scientific article published on 01 January 2014

Assessing the value of risk predictions by using risk stratification tables

artículo científico publicado en 2008

Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions

artículo científico publicado en 2019

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer

artículo científico publicado en 2016

Combining biomarkers to detect disease with application to prostate cancer ⬇️

artículo científico publicado el 1 de octubre de 2003

Commentary: Reporting standards are needed for evaluations of risk reclassification ⬇️

artículo científico publicado el 13 de mayo de 2011

Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs

artículo científico publicado en 2006

Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual

artículo científico publicado en 2018

Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease

artículo científico publicado en 2014

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

artículo científico publicado en 2015

Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

artículo científico publicado en 2013

Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?

artículo científico publicado en 2016

Diagnostic concordance among pathologists interpreting breast biopsy specimens

artículo científico publicado en 2015

Discordant Interpretations of Breast Biopsy Specimens by Pathologists--Reply

artículo científico publicado en 2015

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

artículo científico publicado en 2006

Does the Net Reclassification Improvement Help Us Evaluate Models and Markers?

article

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

artículo científico publicado en 2016

Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation

artículo científico publicado en 1994

Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation ⬇️

artículo científico publicado el 1 de enero de 1993

Endoscopic ultrasound, positron emission tomography, and computerized tomography for lung cancer

scientific article published on 06 August 2003

Estimation and Comparison of Receiver Operating Characteristic Curves

artículo científico publicado en 2009

Evaluating the ROC performance of markers for future events

artículo científico publicado en 2007

Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study

artículo científico publicado en 2016

Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context

artículo científico publicado en 2012

Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer

artículo científico publicado en 2008

Identifying target populations for screening or not screening using logic regression

scientific article published on 01 May 2005

Improving Biomarker Identification with Better Designs and Reporting ⬇️

artículo científico publicado el 1 de agosto de 2011

Improving risk classification of critical illness with biomarkers: a simulation study

artículo científico publicado en 2013

Improving the quality of biomarker discovery research: the right samples and enough of them

artículo científico publicado en 2015

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

artículo científico publicado en 2005

Integrating the predictiveness of a marker with its performance as a classifier

artículo científico publicado en 2007

Joint modeling, covariate adjustment, and interaction: contrasting notions in risk prediction models and risk prediction performance

artículo científico publicado en 2011

LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS.

artículo científico publicado en 2013

Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction"

artículo científico publicado en 2007

Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value

artículo científico publicado en 2007

Measures to summarize and compare the predictive capacity of markers

artículo científico publicado en 2009

Measuring the Performance of Markers for Guiding Treatment Decisions ⬇️

artículo científico publicado el 15 de febrero de 2011

Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test

artículo científico publicado en 2009

Net reclassification indices for evaluating risk prediction instruments: a critical review

scientific article published on January 2014

Net risk reclassification p values: valid or misleading?

artículo científico publicado en 2014

Partial AUC Estimation and Regression ⬇️

artículo científico publicado el 1 de septiembre de 2003

Partially supervised learning using an EM-boosting algorithm

artículo científico publicado en 2004

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation

artículo científico publicado en 2018

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

artículo científico publicado en 2017

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

artículo científico publicado en 2008

Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans

artículo científico publicado en 2004

Problems With Risk Reclassification Methods for Evaluating Prediction Models ⬇️

artículo científico publicado el 9 de mayo de 2011

Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome

artículo científico publicado en 2004

Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes

scientific article published on 01 January 2004

Re: "Clinical Usefulness of the Framingham Cardiovascular Risk Profile beyond Its Statistical Performance: The Tehran Lipid and Glucose Study" ⬇️

artículo científico publicado el 22 de marzo de 2013

Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values

artículo científico publicado en 2018

Sample size calculations for comparative studies of medical tests for detecting presence of disease

artículo científico publicado en 2002

Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.

artículo científico publicado en 2017

Statistical inference for net benefit measures in biomarker validation studies

scientific article published on 16 November 2019

The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers ⬇️

artículo científico publicado el 27 de noviembre de 2012

The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment

artículo científico publicado en 2015

The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets

artículo científico publicado en 2014

The diagnostic challenge of low-grade ductal carcinoma in situ

artículo científico publicado en 2017

The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker

scientific article published on 20 January 2006

The potential of genes and other markers to inform about risk

artículo científico publicado en 2010

Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome.

artículo científico publicado en 2008

Using the ROC curve for gauging treatment effect in clinical trials

artículo científico publicado en 2006

Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective

artículo científico publicado en 2016

Lista de obras de Margaret Sullivan Pepe

A Framework for Evaluating Markers Used to Select Patient Treatment ⬇️

A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection

A framework for evaluating diagnostic discordance in pathology discovered during research studies

A practical multifaceted approach to selecting differentially expressed genes

Accommodating Covariates in ROC Analysis

Adding Rigor to Biomarker Evaluations - EDRN Experience

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting

Adopting nested case–control quota sampling designs for the evaluation of risk markers ⬇️

An approach to evaluating and comparing biomarkers for patient treatment selection

Assessing the value of risk predictions by using risk stratification tables

Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer

Combining biomarkers to detect disease with application to prostate cancer ⬇️

Commentary: Reporting standards are needed for evaluations of risk reclassification ⬇️

Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs

Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual

Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?

Diagnostic concordance among pathologists interpreting breast biopsy specimens

Discordant Interpretations of Breast Biopsy Specimens by Pathologists--Reply

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

Does the Net Reclassification Improvement Help Us Evaluate Models and Markers?

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation

Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation ⬇️

Endoscopic ultrasound, positron emission tomography, and computerized tomography for lung cancer

Estimation and Comparison of Receiver Operating Characteristic Curves

Evaluating the ROC performance of markers for future events

Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study

Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context

Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer

Identifying target populations for screening or not screening using logic regression

Improving Biomarker Identification with Better Designs and Reporting ⬇️

Improving risk classification of critical illness with biomarkers: a simulation study

Improving the quality of biomarker discovery research: the right samples and enough of them

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

Integrating the predictiveness of a marker with its performance as a classifier

Joint modeling, covariate adjustment, and interaction: contrasting notions in risk prediction models and risk prediction performance

LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS.

Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction"

Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value

Measures to summarize and compare the predictive capacity of markers

Measuring the Performance of Markers for Guiding Treatment Decisions ⬇️

Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test

Net reclassification indices for evaluating risk prediction instruments: a critical review

Net risk reclassification p values: valid or misleading?

Partial AUC Estimation and Regression ⬇️

Partially supervised learning using an EM-boosting algorithm

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans

Problems With Risk Reclassification Methods for Evaluating Prediction Models ⬇️

Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome

Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes

Re: "Clinical Usefulness of the Framingham Cardiovascular Risk Profile beyond Its Statistical Performance: The Tehran Lipid and Glucose Study" ⬇️

Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values

Sample size calculations for comparative studies of medical tests for detecting presence of disease

Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.

Statistical inference for net benefit measures in biomarker validation studies

The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers ⬇️

The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment

The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets

The diagnostic challenge of low-grade ductal carcinoma in situ

The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker

The potential of genes and other markers to inform about risk

Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome.

Using the ROC curve for gauging treatment effect in clinical trials

Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective